Envolove : URGENT FDA NOTICE - Pravastatin Sodium Tablets by International Laboratories / Recall - Mislabeling

Author: Erica Lawrence/Friday, August 18, 2017/Categories: APCI Choice

International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. The affected product is NDC# 54458-925-16; Lot# 115698A.

* Please see important information.

Comments are only visible to subscribers.